Our pharmaceutical solutions include active pharmaceutical ingredients (API), finished dosage forms, new drug discovery (NDD), novel drug delivery systems (NDDS) and contract research and manufacturing services (CRAMS).
** Research & Development: We regard our Research & Development (R&D) capabilities as a vital component of our business strategy that provides a sustainable, long-term competitive advantage.
Innovation is at the heart of our research and development. We have been improving our ability to sustain and improve our pipeline of new products. We have a pool of highly qualified R&D scientists with a varied knowledge base and global exposure covering all areas of pharmaceutical research. Our capabilities lie in developing innovative, safe, environment-friendly and cost effective global technologies to deliver high quality APIs and intermediates. The ability to develop difficult-to-make, complex APIs by using the latest technologies is the key differentiating factor of our research.
We have dedicated process development facilities from grams to kilo and pilot scale for process development and process optimization for API1s and advanced pharmaceutical intermediates.
** Manufacturing and CMS(contract manufacturing service): Our state-of-art, FDA approved facilities allow us to manufacture quality active Pharmaceutical Ingredients (APIs) and intermediates that our customers can trust.
** Partnership: At Longwood, we place a high value on our partners on healthcare products, from life-saving medicines to early detection and treatment diagnostic devices and kits. We provide our partners with strong regulatory and marketing support from
Ø We work with our partners to establish alliances that are mutually beneficial, where both parties realize and often exceed strategic goals; Ø We nurture the true value of each partnership and take pride in establishing long-term relationship; Ø We and our partners become stronger together, focusing on what’s important: improve the health and life quality of patients
** Our Partners - Incyte Corporation, USA - Biomerica Inc., USA - Medifuture Co. Ltd., Korea - Shanghai Tengrui Pharmaceuticals Co. Ltd. - Center for Drug Discovery & Technology Development of Yunan Traditional Medicine - Chengda Pharmaceuticals Co. Ltd. |